Literature DB >> 12520143

New ECG criteria for high-risk Brugada syndrome.

Hirotsugu Atarashi1, Satoshi Ogawa.   

Abstract

To identify high-risk patients with Brugada syndrome, the present study reviewed 60 standard 12-lead electrocardiograms from 60 patients collected by the Japanese Brugada syndrome registry. Under blinded conditions, the S wave of lead V(1) was measured from the tip of r to r', and the amplitude of the ST segment in lead V(2) was measured at 0.08 s from the J point. In patients with ventricular fibrillation (n=17), the S wave was significantly longer in V(1) (0.085+/-0.007 s vs 0.075+/-0.011 s, p=0.001), and ST segment elevation in V(2) was significantly greater (0.323+/-0.133 mV vs 0.236+/-0.129 mV, p=0.012) than in patients without fibrillation. An S wave width of 0.08 s or more in V(1) had a positive predictive value of 40.5% and negative predictive value of 100% for ventricular fibrillation, with 100% sensitivity. ST elevation of 0.18 mV or more in V(2) had a positive predictive value of 37.8% and a negative predictive value of 100% for ventricular fibrillation, with 100% sensitivity. Both an S wave width > or =0.08 s in V(1) and ST elevation > or =0.18 mV in V(2) were highly specific indicators of ventricular fibrillation and are proposed as new criteria for high-risk Brugada syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 12520143     DOI: 10.1253/circj.67.8

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  10 in total

1.  Do we intervene inappropriately for ST elevation?

Authors:  A Sanders; A Froude; F Probst
Journal:  Emerg Med J       Date:  2006-02       Impact factor: 2.740

Review 2.  The Brugada Syndrome - Diagnosis, Clinical Implications and Risk Stratification.

Authors:  Velislav N Batchvarov
Journal:  Eur Cardiol       Date:  2014-12

Review 3.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

Review 4.  Brugada syndrome: from cell to bedside.

Authors:  Charles Antzelevitch; Pedro Brugada; Josep Brugada; Ramon Brugada
Journal:  Curr Probl Cardiol       Date:  2005-01       Impact factor: 5.200

Review 5.  Brugada syndrome: recent advances and controversies.

Authors:  Charles Antzelevitch; Eyal Nof
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

6.  Brugada disease: chronology of discovery and paternity. Preliminary observations and historical aspects.

Authors:  Andres Ricardo Perez Riera; Edgardo Schapachnik; Celso Ferreira
Journal:  Indian Pacing Electrophysiol J       Date:  2003-10-01

7.  Feasibility and outcomes of ajmaline provocation testing for Brugada syndrome in children in a specialist paediatric inherited cardiovascular diseases centre.

Authors:  Merlin Ranald McMillan; Thomas George Day; Margarita Bartsota; Sarah Mead-Regan; Rory Bryant; Jasveer Mangat; Dominic Abrams; Martin Lowe; Juan Pablo Kaski
Journal:  Open Heart       Date:  2014-02-12

Review 8.  Electrocardiographic methods for diagnosis and risk stratification in the Brugada syndrome.

Authors:  Abdulrahman Naseef; Elijah R Behr; Velislav N Batchvarov
Journal:  J Saudi Heart Assoc       Date:  2014-07-03

9.  Usefulness of patient's history and non-invasive electrocardiographic parameters in prediction of ajmaline test results in patients with suspected Brugada syndrome.

Authors:  Beata Uziębło-Życzkowska; Grzegorz Gielerak; Dariusz Michałkiewicz
Journal:  Arch Med Sci       Date:  2013-08-12       Impact factor: 3.318

10.  Approach to the asymptomatic patients with Brugada syndrome.

Authors:  Masahiko Takagi; Hiroaki Tatsumi; Minoru Yoshiyama
Journal:  Indian Pacing Electrophysiol J       Date:  2007-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.